Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study
Titel:
Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study
Auteur:
Cavo, Michele Gay, Francesca Beksac, Meral Pantani, Lucia Petrucci, Maria Teresa Dimopoulos, Meletios A Dozza, Luca van der Holt, Bronno Zweegman, Sonja Oliva, Stefania van der Velden, Vincent H J Zamagni, Elena Palumbo, Giuseppe A Patriarca, Francesca Montefusco, Vittorio Galli, Monica Maisnar, Vladimir Gamberi, Barbara Hansson, Markus Belotti, Angelo Pour, Ludek Ypma, Paula Grasso, Mariella Croockewit, Alexsandra Ballanti, Stelvio Offidani, Massimo Vincelli, Iolanda D Zambello, Renato Liberati, Anna Marina Andersen, Niels Frost Broijl, Annemiek Troia, Rossella Pascarella, Anna Benevolo, Giulia Levin, Mark-David Bos, Gerard Ludwig, Heinz Aquino, Sara Morelli, Anna Maria Wu, Ka Lung Boersma, Rinske Hajek, Roman Durian, Marc von dem Borne, Peter A Caravita di Toritto, Tommaso Zander, Thilo Driessen, Christoph Specchia, Giorgina Waage, Anders Gimsing, Peter Mellqvist, Ulf-Henrik van Marwijk Kooy, Marinus Minnema, Monique Mandigers, Caroline Cafro, Anna Maria Palmas, Angelo Carvalho, Susanna Spencer, Andrew Boccadoro, Mario Sonneveld, Pieter